KR920700655A - 주사가능한 클라리트로마이신 조성물 - Google Patents

주사가능한 클라리트로마이신 조성물

Info

Publication number
KR920700655A
KR920700655A KR1019910701690A KR910701690A KR920700655A KR 920700655 A KR920700655 A KR 920700655A KR 1019910701690 A KR1019910701690 A KR 1019910701690A KR 910701690 A KR910701690 A KR 910701690A KR 920700655 A KR920700655 A KR 920700655A
Authority
KR
South Korea
Prior art keywords
composition
stabilizer
acid
therapeutically effective
effective concentration
Prior art date
Application number
KR1019910701690A
Other languages
English (en)
Inventor
위 호-와
슈 청-치앙
비. 캐논 존
더블유. 로벨 마이클
Original Assignee
찰스 엠. 브럭
애보트 래보러토리즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 찰스 엠. 브럭, 애보트 래보러토리즈 filed Critical 찰스 엠. 브럭
Publication of KR920700655A publication Critical patent/KR920700655A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10C—WORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
    • C10C3/00—Working-up pitch, asphalt, bitumen
    • C10C3/002—Working-up pitch, asphalt, bitumen by thermal means
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10C—WORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
    • C10C3/00—Working-up pitch, asphalt, bitumen
    • C10C3/06—Working-up pitch, asphalt, bitumen by distillation
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • D01F9/08—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
    • D01F9/12—Carbon filaments; Apparatus specially adapted for the manufacture thereof
    • D01F9/14—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments
    • D01F9/145—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from pitch or distillation residues
    • D01F9/155—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from pitch or distillation residues from petroleum pitch

Abstract

내용 없음

Description

주사가능한 클라리트로마이신 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (13)

  1. 치료학적 유효농도의 클라리트로마이신, 트리글리세라이드 오일 및 1개 이상의 안정화제를 포함하는주사가능한 지방성 유제를 함유하는 약제학적 조성물.
  2. 제1항에 있어서, 추가로 유화제를 포함하는 조성물.
  3. 제2항에 있어서, 유화제가 계란 인지질인조성물.
  4. 제1항에 있어서, 트리글리세라이드 오일이 C6-10지방족 지방산을 갖는 오일인 조성물.
  5. 제1항에 있어서, 안정화제가 C6-12포화지방산 또는 C16-18불포화 지방산 중에서 선택되는 조성물.
  6. 제1항에 있어서, 안정화제가 데칸산, 옥탄산, 올레산, 헥산산, N-메틸 피롤리돈, 벤질 알콜 및 메틸렌 클로라이드 중에서 선택되는 조성물.
  7. 제6항에 있어서, 안정화제가 데칸산인 조성물.
  8. 제6항에 있어서, 안정화제가 N-메틸 피롤리돈인 산물.
  9. 제6항에 있어서, 안정화제가 올레산과 헥산산의 혼합물인 조성물.
  10. 제1항에 있어서, 치료학적 유효 농도가 약 2.5내지 약 10mg/㎖인 조성물.
  11. 제10항에 있어서, 치료학적 유효 농도가 약 5mg/㎖인 조성물.
  12. 제2항에 있어서, 추가로 긴장성-조절제를 포함하는 조성물.
  13. 치료학적 유효농도의 클라리트로마이신, 대두유, 계란 인지질, 올레산, 헥산산 및 글리세린을 포함하는 주사가능한 지방성 유제를 함유하는 약제학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910701690A 1989-05-26 1990-05-25 주사가능한 클라리트로마이신 조성물 KR920700655A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35828389A 1989-05-26 1989-05-26
US07/358283 1989-05-26
PCT/US1990/003063 WO1990014094A1 (en) 1989-05-26 1990-05-25 Injectable clarithromycin composition

Publications (1)

Publication Number Publication Date
KR920700655A true KR920700655A (ko) 1992-08-10

Family

ID=23409043

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910701690A KR920700655A (ko) 1989-05-26 1990-05-25 주사가능한 클라리트로마이신 조성물

Country Status (9)

Country Link
EP (1) EP0473707A4 (ko)
JP (1) JP2963537B2 (ko)
KR (1) KR920700655A (ko)
AU (1) AU630469B2 (ko)
CA (1) CA2056445A1 (ko)
GR (1) GR1002177B (ko)
IL (1) IL94516A (ko)
NZ (1) NZ233827A (ko)
WO (1) WO1990014094A1 (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
DE4447972B4 (de) * 1993-05-27 2007-12-27 Novartis Ag Galenische Formulierungen
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
KR970702725A (ko) * 1994-04-26 1997-06-10 노부히로 나리따 비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
CN1617709A (zh) * 2001-12-13 2005-05-18 兰贝克赛实验室有限公司 克拉霉素的稳定局部制剂
US20050049209A1 (en) * 2003-08-06 2005-03-03 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8349882B2 (en) * 2006-03-08 2013-01-08 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
RU2419429C2 (ru) 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
JP5345937B2 (ja) 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
CN101808637B (zh) 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
JP5453093B2 (ja) 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102481286B (zh) 2009-08-25 2014-02-26 宝丽制药股份有限公司 抗真菌药物组合物
RU2707748C2 (ru) 2013-11-08 2019-11-29 Активус Фарма Ко., Лтд. Композиция водной суспензии, включающая наночастицы макролидных антибиотиков
WO2018185557A1 (en) * 2017-04-03 2018-10-11 The Center For Digestive Diseases Administration of antibiotic compounds for the treatment of streptococcal infections for the treatment of psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61291520A (ja) * 1985-06-19 1986-12-22 Daigo Eiyou Kagaku Kk エリスロマイシン脂肪乳剤
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
US5338761A (en) * 1988-09-29 1994-08-16 Shiseido Company Ltd. Emulsified composition

Also Published As

Publication number Publication date
AU5811090A (en) 1990-12-18
WO1990014094A1 (en) 1990-11-29
NZ233827A (en) 1991-06-25
IL94516A0 (en) 1991-03-10
GR900100402A (el) 1991-10-10
AU630469B2 (en) 1992-10-29
IL94516A (en) 1994-12-29
JP2963537B2 (ja) 1999-10-18
CA2056445A1 (en) 1990-11-27
EP0473707A4 (en) 1992-12-09
JPH04505762A (ja) 1992-10-08
EP0473707A1 (en) 1992-03-11
GR1002177B (en) 1996-03-07

Similar Documents

Publication Publication Date Title
KR920700655A (ko) 주사가능한 클라리트로마이신 조성물
DE59008336D1 (de) Orale Lipidarzneiform.
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
KR900002771A (ko) 지방산 조성물
DK312583A (da) Kortikoidholdigt praeparat til topisk applikation
DK0648076T3 (da) Mikroindkapslet olie- eller fedtstofprodukt
KR850000972A (ko) 지용성 약제 물질을 함유한 수용액
BRPI0614084A2 (pt) composição estável de emulsão de óleo-em-água de propofol, administrável por via intranovesa; e processo de preparação de uma composição
KR910009163A (ko) 물 함유 초콜렛의 제조방법
KR900007350A (ko) 제조된, 베타-프라임 안정성 트리글리세라이드 경질스톡
KR960705585A (ko) 경비조성물 및 그것을 함유하는 경비제제(pernasal composition and pernasal preparation containing the saem)
KR890700021A (ko) 인지질 조성물
KR900701174A (ko) 인지질-함유 조성물, 이의 제조방법 및 이의 약제학적 물질용 부형제로서의 용도
KR900012612A (ko) 제약 조성물
Stenson et al. Effects of dietary fish oil supplementation on membrane fluidity and enzyme activity in rat small intestine
ES2064801T3 (es) Emusion estable apropiada para la administracion farmaceutica, procedimiento para su obtencion, y emulsion para la aplicacion como medicamento.
US20110129504A1 (en) Composition for controlling lipase catalyzed reactions
CA2134658A1 (en) Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
KR930702965A (ko) 생체이용성이 개선된 프로부콜 함유 제약 조성물
KR920014422A (ko) 크리임상 조성물의 제법
KR910007509A (ko) 친유성 약제용 주사 조성물
KR970014571A (ko) 1,2-디브로모-2,4-디시아노부탄과 파라하이드록시벤조산 에스테르와의 상승작용성 항미생물성 조성물
KR890001451A (ko) 기포성 수중유형 에멀션의 제조법
KR870007089A (ko) 기름속 물형 에멀젼 폭약
ES2059827T3 (es) Emulsion para administracion parenteral.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid